Katrin Andreasson

Role of immediate early gene expression in cortical morphogenesis and plasticity.

Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response.

Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction.

Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis.

Prostaglandin D2 mediates neuronal protection via the DP1 receptor.

Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia.

Cyclooxygenase-dependent lipid-modification of brain proteins.

Sex differences in cell death.

Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

Trial of celecoxib in amyotrophic lateral sclerosis.

Divergent effects of prostaglandin receptor signaling on neuronal survival.

COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity.

Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.

Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment.

Emerging roles of PGE2 receptors in models of neurological disease.

The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity.

Prostaglandin signalling in cerebral ischaemia.

Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold.

Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.

Signaling via the prostaglandin Eâ‚‚ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia.